Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. …
Over the last 12 months, insiders at Retractable Technologies, Inc. have bought $748,222 and sold $0 worth of Retractable Technologies, Inc. stock.
On average, over the past 5 years, insiders at Retractable Technologies, Inc. have bought $529,516 and sold $1.49M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SHAW THOMAS J (PRESIDENT AND CEO) — $748,222.
The last purchase of 8,657 shares for transaction amount of $6,128 was made by SHAW THOMAS J (PRESIDENT AND CEO) on 2024‑11‑01.
2024-11-01 | PRESIDENT AND CEO | 8,657 0.0288% | $0.71 | $6,128 | +1.86% | |||
2024-10-30 | PRESIDENT AND CEO | 601 0.002% | $0.71 | $429 | +1.08% | |||
2024-10-24 | PRESIDENT AND CEO | 11,441 0.036% | $0.71 | $8,180 | 0.00% | |||
2024-10-23 | PRESIDENT AND CEO | 21,142 0.0688% | $0.74 | $15,662 | 0.00% | |||
2024-10-18 | PRESIDENT AND CEO | 8,104 0.0266% | $0.75 | $6,062 | -4.93% | |||
2024-10-10 | PRESIDENT AND CEO | 6,234 0.0215% | $0.74 | $4,632 | +0.52% | |||
2024-10-01 | PRESIDENT AND CEO | 5,744 0.02% | $0.75 | $4,319 | -0.85% | |||
2024-09-25 | PRESIDENT AND CEO | 9,663 0.0326% | $0.73 | $7,021 | -0.77% | |||
2024-09-20 | PRESIDENT AND CEO | 71,422 0.2524% | $0.82 | $58,859 | -2.59% | |||
2024-09-19 | PRESIDENT AND CEO | 27,710 0.0913% | $0.89 | $24,576 | -15.51% | |||
2024-09-18 | PRESIDENT AND CEO | 1,180 0.0039% | $0.89 | $1,051 | -14.65% | |||
2024-09-16 | PRESIDENT AND CEO | 450 0.0015% | $0.90 | $404 | -15.32% | |||
2024-09-10 | PRESIDENT AND CEO | 8,577 0.0289% | $0.91 | $7,812 | -15.27% | |||
2024-09-05 | PRESIDENT AND CEO | 5,251 0.0175% | $0.91 | $4,799 | -16.26% | |||
2024-09-03 | PRESIDENT AND CEO | 15,096 0.0506% | $0.92 | $13,937 | -16.34% | |||
2024-08-27 | PRESIDENT AND CEO | 8,747 0.029% | $0.94 | $8,248 | -18.75% | |||
2024-08-26 | PRESIDENT AND CEO | 134 0.0004% | $0.94 | $127 | -18.71% | |||
2024-08-15 | PRESIDENT AND CEO | 3,652 0.0116% | $0.99 | $3,615 | 0.00% | |||
2024-08-14 | PRESIDENT AND CEO | 13,924 0.0447% | $1.00 | $13,934 | 0.00% | |||
2024-08-05 | PRESIDENT AND CEO | 15,458 0.0504% | $0.99 | $15,252 | -11.14% |
SHAW THOMAS J | PRESIDENT AND CEO | 14815493 49.4886% | $0.74 | 473 | 0 | +87.91% |
Leonard Braden Michael | director | 688575 2.3001% | $0.74 | 5 | 3 | <0.0001% |
Laterza Marco | director | 10000 0.0334% | $0.74 | 1 | 0 | <0.0001% |
Findley Darren E | director | 4200 0.014% | $0.74 | 1 | 0 | +96.84% |
KUHLMAN RUSSELL B | VP - Sales | 0 0% | $0.74 | 1 | 3 |
The Vanguard Group | $838,730.00 | 2.34 | 698,941 | 0% | +$0 | <0.0001 | |
Renaissance Technologies | $431,000.00 | 1.2 | 358,893 | +44.38% | +$132,483.75 | <0.01 | |
BlackRock | $329,520.00 | 0.92 | 274,599 | -0.85% | -$2,833.21 | <0.0001 | |
Bridgeway Capital Management | $179,441.00 | 0.5 | 149,534 | 0% | +$0 | <0.01 | |
Geode Capital Management | $164,633.00 | 0.46 | 137,173 | 0% | +$0 | <0.0001 |